CTLA4 and cancer: The blockade of both targets, CTLA-4 and PD-1, currently constitutes the first line of cancer treatment along with the two classical treatments, chemo- and radiotherapy, which indicates the importance of novel discoveries trying to improve the efficacy of immunotherapy.